GOLDMAN SACHS GROUP INC - KYMERA THERAPEUTICS INC ownership

KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 129 filers reported holding KYMERA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of KYMERA THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$13,799,924
-23.8%
462,309
+2.6%
0.00%
-33.3%
Q1 2024$18,110,823
+5.4%
450,518
-33.2%
0.00%0.0%
Q4 2023$17,176,716
+503.7%
674,655
+229.6%
0.00%
+200.0%
Q3 2023$2,845,441
-63.8%
204,708
-40.1%
0.00%
-50.0%
Q2 2023$7,852,120
-10.7%
341,545
+15.1%
0.00%0.0%
Q1 2023$8,795,458
+4.3%
296,843
-12.2%
0.00%0.0%
Q4 2022$8,434,733
+114955.7%
337,930
+0.3%
0.00%0.0%
Q3 2022$7,331
+34.3%
336,759
+21.5%
0.00%
+100.0%
Q2 2022$5,459
-99.9%
277,264
+13.7%
0.00%
-50.0%
Q1 2022$10,323,000
-39.3%
243,926
-8.9%
0.00%
-33.3%
Q4 2021$17,002,000
+60.6%
267,790
+48.6%
0.00%
+50.0%
Q3 2021$10,585,000
+172.7%
180,207
+125.3%
0.00%
+100.0%
Q2 2021$3,881,000
+589.3%
80,003
+451.9%
0.00%
Q1 2021$563,000
-67.5%
14,496
-48.1%
0.00%
Q4 2020$1,732,000
-63.7%
27,930
-81.1%
0.00%
-100.0%
Q3 2020$4,773,000147,7380.00%
Other shareholders
KYMERA THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Atlas Venture Life Science Advisors, LLC 5,984,736$149,379,01117.99%
Aquilo Capital Management, LLC 629,411$15,710,0995.90%
BVF INC/IL 4,692,604$117,127,3964.94%
Artal Group S.A. 2,000,000$49,9202.79%
Redmile Group, LLC 2,673,837$66,738,9722.73%
Avoro Capital Advisors LLC 3,850,000$96,096,0001.44%
Deer Management Co. LLC 615,895$15,372,7391.42%
AtonRa Partners 27,125$677,0400.86%
Rock Springs Capital Management LP 1,227,779$30,645,3640.74%
EcoR1 Capital, LLC 796,093$19,870,4810.60%
View complete list of KYMERA THERAPEUTICS INC shareholders